SYMFI 600 mg/1
Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate · TABLET, FILM COATED · Viatris Specialty LLC
No Recall History
Plain English
SYMFI is a tablet, film coated containing efavirenz, lamivudine and tenofovir disoproxil fumarate at 600 mg/1, taken oral. Manufactured by Viatris Specialty LLC.
Key Facts
- Brand Name
- SYMFI
- Generic Name
- Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate
- NDC Code (Product)
49502-475- Manufacturer
- Viatris Specialty LLC
- Strength
- 600 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA022142
- Drug Class
- Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
- Marketing Start
- 04/25/2018
Recall History
No Recall HistoryFrequently Asked Questions
What is SYMFI used for?
SYMFI contains Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate. It is a tablet, film coated taken oral. Consult your doctor for specific uses.
Is SYMFI a controlled substance?
SYMFI is not classified as a controlled substance by the DEA.
What is the generic name for SYMFI?
The generic name for SYMFI is Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate. There are 2 other brand versions of Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate.
What is the NDC code for SYMFI 600 mg/1?
The NDC (National Drug Code) for SYMFI 600 mg/1 is 49502-475, listed by Viatris Specialty LLC.